ES556026A0 - Un procedimiento para preparar derivados de tienopiridona - Google Patents

Un procedimiento para preparar derivados de tienopiridona

Info

Publication number
ES556026A0
ES556026A0 ES556026A ES556026A ES556026A0 ES 556026 A0 ES556026 A0 ES 556026A0 ES 556026 A ES556026 A ES 556026A ES 556026 A ES556026 A ES 556026A ES 556026 A0 ES556026 A0 ES 556026A0
Authority
ES
Spain
Prior art keywords
thenopiridone
procedure
preparing derivatives
derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556026A
Other languages
English (en)
Other versions
ES8707243A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of ES8707243A1 publication Critical patent/ES8707243A1/es
Publication of ES556026A0 publication Critical patent/ES556026A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
ES556026A 1985-06-15 1986-06-13 Un procedimiento para preparar derivados de tienopiridona Expired ES8707243A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858515207A GB8515207D0 (en) 1985-06-15 1985-06-15 Therapeutic agents

Publications (2)

Publication Number Publication Date
ES8707243A1 ES8707243A1 (es) 1987-07-16
ES556026A0 true ES556026A0 (es) 1987-07-16

Family

ID=10580803

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556026A Expired ES8707243A1 (es) 1985-06-15 1986-06-13 Un procedimiento para preparar derivados de tienopiridona

Country Status (20)

Country Link
US (1) US4710506A (es)
EP (1) EP0209977A3 (es)
JP (1) JPS6236382A (es)
KR (1) KR870000339A (es)
AU (1) AU581595B2 (es)
CS (1) CS258483B2 (es)
DD (1) DD253823A5 (es)
DK (1) DK272486A (es)
ES (1) ES8707243A1 (es)
FI (1) FI862520L (es)
GB (1) GB8515207D0 (es)
GR (1) GR861527B (es)
HU (1) HU195661B (es)
JO (1) JO1482B1 (es)
NO (1) NO862373L (es)
PH (1) PH22293A (es)
PL (1) PL266392A1 (es)
PT (1) PT82759B (es)
YU (2) YU99386A (es)
ZA (1) ZA864396B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
US4767766A (en) * 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
RU2150470C1 (ru) * 1994-04-19 2000-06-10 Такеда Кемикал Индастриз Лтд. Бициклические производные тиофена, способ их получения и композиция на их основе
EP1107759A1 (en) * 1998-08-03 2001-06-20 Basf Corporation Pyridinones for the treatment of sexual dysfunction
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
WO2003000194A2 (en) * 2001-06-21 2003-01-03 Pfizer Inc. Thienopyridine and thienopyrimidine anticancer agents
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
US8658670B2 (en) * 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection
US7973050B2 (en) * 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
WO2008039639A2 (en) * 2006-09-26 2008-04-03 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US7994192B2 (en) * 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US8697720B2 (en) 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997545A (en) * 1973-07-23 1976-12-14 Takeda Chemical Industries, Ltd. Thienopyridine-carboxylic acid derivatives
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS5742690A (en) * 1980-08-28 1982-03-10 Kanebo Ltd Thieno 3,2-b pyridinecarboxylic acid derivative
GB2085441B (en) * 1980-09-26 1984-10-17 Boots The Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
NO862373D0 (no) 1986-06-13
DK272486A (da) 1986-12-16
JO1482B1 (en) 1988-03-10
FI862520A7 (fi) 1986-12-16
PT82759B (en) 1988-05-12
AU581595B2 (en) 1989-02-23
YU121187A (en) 1988-04-30
GB8515207D0 (en) 1985-07-17
GR861527B (en) 1986-10-14
ES8707243A1 (es) 1987-07-16
CS258483B2 (en) 1988-08-16
US4710506A (en) 1987-12-01
HU195661B (en) 1988-06-28
NO862373L (no) 1986-12-16
PL266392A1 (en) 1988-02-18
FI862520L (fi) 1986-12-16
ZA864396B (en) 1987-08-26
FI862520A0 (fi) 1986-06-12
DK272486D0 (da) 1986-06-10
DD253823A5 (de) 1988-02-03
KR870000339A (ko) 1987-02-17
PH22293A (en) 1988-07-22
PT82759A (en) 1986-07-01
AU5838386A (en) 1986-12-18
CS436286A2 (en) 1987-12-17
HUT42775A (en) 1987-08-28
JPS6236382A (ja) 1987-02-17
EP0209977A2 (en) 1987-01-28
YU99386A (en) 1988-04-30
EP0209977A3 (en) 1988-06-08

Similar Documents

Publication Publication Date Title
ES554380A0 (es) Un procedimiento para preparar derivados de 8-fenilxantina
ES554567A0 (es) Un procedimiento para preparar derivados de 8-amino-purina
ES557215A0 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida
ES555646A0 (es) Un procedimiento para producir derivados de 4-0-sulfonil-uracilo
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES550819A0 (es) Un procedimiento para preparar nuevos derivados de cefem.
ES554286A0 (es) Un procedimiento para la preparacion de nuevos derivados glicopepticos
ES550875A0 (es) Procedimiento para preparar derivados de imidazolilalquil- quilguanidina
ES552091A0 (es) Un procedimiento para preparar derivados arilicos de dienamidas
ES553952A0 (es) Un procedimiento para preparar derivados sinteticos de pseudopterosina
ES556027A0 (es) Un procedimiento para preparar derivados de quinolona
ES552617A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES554238A0 (es) Un precedimiento para preparar derivados de ciclopentil-eter
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES543236A0 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES553814A0 (es) Un procedimiento para preparar nuevos derivados de aminocetona
ES548960A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES553467A0 (es) Un procedimiento para preparar derivados de dihidropiridazina
ES554371A0 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES550525A0 (es) Un procedimiento para preparar un derivado de piridinilmeti-cetona
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES551252A0 (es) Un procedimiento para preparar derivados de 4 4-dialquil- -2-azetidinomas
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c
ES548744A0 (es) Procedimiento para preparar un derivado de pirrolidina